Molecular Partners AG (0QXX.L)

CHF 3.4

(-5.82%)

Long Term Debt Summary of Molecular Partners AG

Molecular Partners AG's latest annual long term debt in 2023 was 2.44 Million CHF , down -33.08% from previous year.
Molecular Partners AG's latest quarterly long term debt in 2024 Q2 was 1.83 Million CHF , down 0.0% from previous quarter.
Molecular Partners AG reported annual long term debt of 3.65 Million CHF in 2022, down -24.7% from previous year.
Molecular Partners AG reported annual long term debt of 4.85 Million CHF in 2021, down -19.69% from previous year.
Molecular Partners AG reported quarterly long term debt of - CHF for 2024 Q3, down 0.0% from previous quarter.
Molecular Partners AG reported quarterly long term debt of 1.83 Million CHF for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Molecular Partners AG (2023 - 2013)

Historical Annual Long Term Debt of Molecular Partners AG (2023 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2023	2.44 Million CHF	-33.08%
2022	3.65 Million CHF	-24.7%
2021	4.85 Million CHF	-19.69%
2020	6.03 Million CHF	372.54%
2019	1.27 Million CHF	0.0%
2018	- CHF	0.0%
2017	- CHF	0.0%
2016	- CHF	0.0%
2015	- CHF	0.0%
2014	- CHF	0.0%
2013	- CHF	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	2.14 Million CHF	0.0%
2024 Q3	- CHF	0.0%
2024 Q2	1.83 Million CHF	0.0%
2023 Q1	3.35 Million CHF	-8.27%
2023 Q3	2.74 Million CHF	-9.9%
2023 Q2	3.04 Million CHF	-8.99%
2023 Q4	2.44 Million CHF	-11.03%
2023 FY	2.44 Million CHF	-33.08%
2022 Q3	3.95 Million CHF	-7.06%
2022 Q1	4.55 Million CHF	-6.16%
2022 FY	3.65 Million CHF	-24.7%
2022 Q4	3.65 Million CHF	-7.59%
2022 Q2	4.25 Million CHF	-6.57%
2021 Q4	4.85 Million CHF	-5.79%
2021 FY	4.85 Million CHF	-19.69%
2021 Q3	5.14 Million CHF	-5.45%
2021 Q2	5.44 Million CHF	-5.17%
2021 Q1	5.74 Million CHF	-4.92%
2020 Q1	- CHF	-100.0%
2020 FY	6.03 Million CHF	372.54%
2020 Q2	640 Thousand CHF	0.0%
2020 Q4	6.03 Million CHF	0.0%
2019 FY	1.27 Million CHF	0.0%
2019 Q3	1.27 Million CHF	-32.84%
2019 Q2	1.9 Million CHF	0.0%
2019 Q1	1.9 Million CHF	0.0%
2019 Q4	1.27 Million CHF	0.0%
2018 Q4	- CHF	0.0%
2018 Q3	- CHF	0.0%
2018 Q1	- CHF	0.0%
2018 Q2	- CHF	0.0%
2018 FY	- CHF	0.0%
2017 Q1	- CHF	0.0%
2017 FY	- CHF	0.0%
2017 Q4	- CHF	0.0%
2017 Q3	- CHF	0.0%
2017 Q2	- CHF	0.0%
2016 Q3	- CHF	0.0%
2016 Q2	- CHF	0.0%
2016 Q1	- CHF	0.0%
2016 FY	- CHF	0.0%
2016 Q4	- CHF	0.0%
2015 Q4	- CHF	0.0%
2015 Q2	- CHF	0.0%
2015 FY	- CHF	0.0%
2015 Q1	- CHF	0.0%
2014 Q4	- CHF	0.0%
2014 FY	- CHF	0.0%
2014 Q1	- CHF	0.0%
2013 FY	- CHF	0.0%

Peer Long Term Debt Comparison of Molecular Partners AG

Name	Long Term Debt	Long Term Debt Difference
Relief Therapeutics Holding AG	9000.00 CHF	-27055.556%
Tecan Group AG	303.85 Million CHF	99.196%
Santhera Pharmaceuticals Holding AG	1.47 Million CHF	-65.359%
Basilea Pharmaceutica AG	95.45 Million CHF	97.44%
Bachem Holding AG	218 Thousand CHF	-1021.101%
Siegfried Holding AG	525 Million CHF	99.534%